PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Engineered Stabilization Device is now recommended by the National ...

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces the SecurAcath is one of only four medical technologies to be included in the new MedTech Funding ...

Interrad Medical, Inc. a privately held medical device company, announced today that it has raised approximately $10 million in its Series C financing. The funding was raised through a private ...

Plymouth, MN-based Interrad Medical has raised approximately $10 million in Series C financing through a private placement by RBC Wealth Management Group. The financing will be used to support the ...

The company identified 3 published economic studies, but the external assessment centre considered them to be outside the scope. It did not identify any further economic studies. The company presented ...

Interrad Medical has announced it has received FDA clearance for four new sizes of the SecurAcath subcutaneous catheter securement device, according to a news release ...

Interrad Medical has received Food and Drug Administration approval for its SecurAcath Universal Subcutaneous Catheter Securement System. The device holds indwelling catheters in place. Rather than ...

Each year, health care professionals worldwide insert 500 million vascular access catheters into patients’ veins for blood draws or intravenous medications. Traditionally, catheters are attached to ...

FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...